In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.
Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.
Anglo-Dutch antibody specialist PanGenetics BV has agreed a collaboration with Lay Line Genomics SpA of Rome, Italy, in the field of therapeutic antibodies for the treatment of pain.
Pharminox Ltd, a private oncology R&D company backed by IP Group, is to carry out joint research into novel small molecule chemotherapeutics with Schering-Plough.
The UK is setting up a national network to carry out clinical trials of paediatric medicines, filling the gap left by pharmaceutical companies which usually test drugs only on adults.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.